Amy Rosenfeld regularly sends me papers and preprints, mostly on viruses but not always. Here they are for your enjoyment and education.
Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans (Ann Int Med)
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels (Nat Cardio Res)
Viral kinetics of sequential SARS-CoV-2 infections (Nat Comm)
History of primary-series and booster vaccination and protection against Omicron reinfection (Sci Adv)
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice (Cell Rep)
Distinguishing features of Long COVID identified through immune profiling (Nature)
Host range, transmissibility and antigenicity of a pangolin coronavirus (Nat Micro)
Does Everyone Need a Yearly Covid Booster? (Beyond the Noise)
Closing in on Zero: Adapting to Complexity and risk on the path to end polio (Polio Eradication pdf)
Postacute sequelae of COVID-19 at 2 years (Nat Med)
Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets (Cell)
Mpox infection protects against re-challenge in rhesus macaques (Cell)
Mpox cases rise in China, but response is affected by anti-LGBTQ bias and ‘technology nationalism’ (South China Morning Post)
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3 (Nature)
IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus (Sci Adv)
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic (bioRxiv)
The Case for Studying New Viruses of New Hosts (Ann Rev Virol)
FDA Approves New Drug to Prevent RSV in Babies and Toddlers (FDA)
WHO reports dozens of babies sickened by deadly viral infections (NBC News)
Memory B cells (Nat Rev Immunol)
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo (Nat Commun)
Rare link between coronavirus vaccines and Long Covid–like illness starts to gain acceptance (Science)
Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response (Nat Comm)
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses (Cell Rep Med)
Understanding the Risk of Bat Coronavirus Emergence (EcoHealth Alliance)
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine (Sci Transl Med)
A novel bat coronavirus with a polybasic furin-like cleavage site (Virologica Sinica)
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity (Nat Genetics)
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape (Nat Comm)
Functional T cells are capable of supernumerary cell division and longevity (Nature)
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses (Immunity)
Long-term gastrointestinal outcomes of COVID-19 (Nat Comm)
Sarbecoviruses of British Horseshoe Bats; Sequence Variation and Epidemiology (bioRxiv)
Archival wild-type poliovirus 1 infected central nervous system tissues of the pre-vaccination era in Switzerland reveal a distinct virus genotype (Acta Neuropath)
Evidence for an aquatic origin of influenza virus and the order Articulavirales (bioRxiv)
Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats (bioRxiv)
The crystal structure of a simian Foamy Virus receptor binding domain provides clues about entry into host cells (Nature Comm)
Influenza at the human-animal interface: Summary and risk assessment, from 6 to 26 January 2023 (WHO)
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines (Cell Rep Med)
Pre-existing immunity modulates responses to mRNA boosters (Cell Rep)
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster (bioRxiv)
Equatorial Guinea confirms first-ever Marburg virus disease outbreak (WHO)
Cross-protective antibodies against common endemic respiratory viruses (Nat Comm)
Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the percentage of people who have been infected with COVID-19 by variant and age, England: 9 February 2023 (UK Office for National Statistics)
The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England (Nat Comm)
Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022 (Eurosurveillance)
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5 (Lancet Inf Dis)
How quickly does COVID immunity fade? What scientists know (Nature)
Effectiveness of Bivalent Boosters against Severe Omicron Infection (NEJM)
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 (Clin Immunol)
Facing the New Covid-19 Reality (NEJM)
U.S. scientists brace for tighter scrutiny of potentially risky research (Science)
Real-world effectiveness of a single dose of mpox vaccine in males (Nature Med)
COVID-19 vaccines versus pediatric hospitalization (Cell Rep Med)
Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters (bioRxiv)
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape (Nat Comm)
Functional T cells are capable of supernumerary cell division and longevity (Nature)
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection (Lancet Inf Dis)
Bivalent Covid-19 Vaccines — A Cautionary Tale (NEJM)
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response (Nat Comm).
Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months (Lancet Inf Dis)
Wastewater surveillance for public health (Science).
Continuous germinal center invasion contributes to the diversity of the immune response (Cell)
Massive measles outbreak threatens India’s goal to eliminate disease by 2023 (Nature)
SARS-CoV-2 infection and persistence in the human body and brain at autopsy (Nature)
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice (Cell Rep Med)
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave (Nature Med)
Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines in US veterans (Nature Micro)
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants (Cell)
The WHO estimates of excess mortality associated with the COVID-19 pandemic (Nature)
COVID drug Paxlovid was hailed as a game-changer. What happened? (Nature)
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster (NEJM)
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution (Nature)
Impact of SARS-CoV-2 exposure history on the T cell and IgG response (Cell Rep Med)
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection (Nat Immunol)
Antibody effector functions are associated with protection from respiratory syncytial virus (Cell)
An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2 (Cell Host Microbe)
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB (NEJM)
Nearly 40 million children susceptible to measles due to COVID-19 disruptions (United Nations) note: the young girl in the photo is NOT receiving a measles vaccine; that is given by needle intramuscularly. The girl is receiving oral poliovirus vaccine. (vrr)
Vaccines are in short supply amid global cholera surge (Science)
Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans (Cell Host Microbe)
SARS-CoV-2 viral load and shedding kinetics (Nat Rev Micro)
There is currently a measles outbreak in Ohio among unvaccinated children. This webpage has case details: Measles Public Report
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination (Clin Res Cardiol)
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study (Can Med Assoc J)
Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response (Cell Rep)
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination (bioRxiv)
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design (Cell Rep Med)
Differential mosquito attraction to humans is associated with skin-derived carboxylic acid levels (Cell)
Pathogen spillover driven by rapid changes in bat ecology (Nature)
Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses (Nat Genet)
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies (Cell Rep Med)
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques (Science)
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design (Cell Rep Med)
Chlamydia repurposes the actin-binding protein EPS8 to disassemble epithelial tight junctions and promote infection (Cell Host Microbe)
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination (J Exp Med)
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (Nat Micro)
Chances of finding COVID-virus ancestor ‘almost nil’, say virologists (Nature)
Associations between indoor relative humidity and global COVID-19 outcomes (J R Soc Interface)
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial (Nat Micro)
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients (medRxiv)
Acute and postacute sequelae associated with SARS-CoV-2 reinfection (Nat Med)
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations (Nat Micro)
Lifting Universal Masking in Schools – Covid-19 Incidence among Students and Staff (NEJM)
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine (Cell Rep)
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in macaques (Cell)
Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 (medRxiv)
Shared genetic influences between blood analyte levels and risk of severe COVID-19 (Cell Rep)
Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review (Heliyon)
Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum (Cell Discovery)
mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1 (bioRxiv)
Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum (Cell Discovery)
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex (NPJ Vaccines)
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters (bioRxiv)
Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot (bioRxiv)
Sterilizing immunity: Understanding COVID-19 (Immunity)
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel (NEJM)
Heart risks, data gaps fuel debate over COVID-19 boosters for young people (Science)
The Pfizer COVID-19 vaccine doesn’t prevent transmission: Antivax disinformation goes viral again (Science Based Medicine)
New vaccine to protect people in the EU and worldwide against dengue (European Medicines Agency)
Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study (Lancet Glob Health)
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study (Nat Comm)
Boosting with updated COVID-19 mRNA vaccines (Nat Med)
The neurobiology of long COVID (Neuron)
Seasonality of Common Human Coronaviruses, United States, 2014–2021 (Emerg Inf Dis)
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines (Cell Rep Med)
SARS-CoV-2 Omicron variant emerged under immune selection (Nat Micr)